The Asia Pacific Electronic Data Capture Systems Market would witness market growth of 14.8% CAGR during the forecast period (2022-2028).
EDC has the potential to both improve the precision of the data and shorten the amount of time needed to gather it for research on pharmaceuticals and medical equipment. When it comes to adopting an EDC system to assist their drug development, many drug researchers discover that there is a rather high start-up procedure, which is then followed by large advantages throughout the course of the trial.
This is the trade-off that they confront. Therefore, in order for an EDC to be cost-effective, the total amount of money saved throughout the course of the trial should be more than the initial investment required to set it up. The conventional and relatively tedious procedure of handling clinical trial data is being replaced with an electronic system as a result of electronic data capture (EDC) software.
The primary function of EDC software is to simplify the processes of data gathering, review, and processing for clinical trials. EDC software is an essential component of clinical trial management software; in fact, some CTMS packages even have integrated EDC capabilities. The use of EDC software may increase a company's capacity to maintain regulatory compliance, as well as the quality of the data collected and the speed with which studies are conducted.
China has one of the populations that is becoming older at one of the quickest rates in the world. It is anticipated that by the year 2040, the proportion of China's population that is over 60 years old will reach 28 percent, thanks to rising life expectancy and falling birth rates. This enormous demographic shift presents many new challenges and opportunities for public health and socioeconomic development; in particular, the advancement of an integrated system that appeals to the health and social requirements of older people, with comparable access to health care regardless of geographic area, is one of the most important of these new challenges and opportunities.
The China market dominated the Asia Pacific Electronic Data Capture Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $183.1 million by 2028.The Japan market is estimated to grow a CAGR of 14.1% during (2022 - 2028). Additionally, The India market would experience a CAGR of 15.5% during (2022 - 2028).
Based on Component, the market is segmented into Services and Software. Based on End User, the market is segmented into CROs, Pharmaceutical & Biotechnology Firms, Hospitals/Healthcare providers, Medical Device Firms and Others. Based on Development Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Delivery Mode, the market is segmented into Web & Cloud-based and On-premise. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, IBM Corporation, Veeva Systems, Inc., IQVIA Holdings, Inc., Medidata Solutions, Inc. (Dassault Systems SE), OpenClinica, LLC, DATATRAK International, Inc., Clario, Castor EDC, and Calyx.
EDC has the potential to both improve the precision of the data and shorten the amount of time needed to gather it for research on pharmaceuticals and medical equipment. When it comes to adopting an EDC system to assist their drug development, many drug researchers discover that there is a rather high start-up procedure, which is then followed by large advantages throughout the course of the trial.
This is the trade-off that they confront. Therefore, in order for an EDC to be cost-effective, the total amount of money saved throughout the course of the trial should be more than the initial investment required to set it up. The conventional and relatively tedious procedure of handling clinical trial data is being replaced with an electronic system as a result of electronic data capture (EDC) software.
The primary function of EDC software is to simplify the processes of data gathering, review, and processing for clinical trials. EDC software is an essential component of clinical trial management software; in fact, some CTMS packages even have integrated EDC capabilities. The use of EDC software may increase a company's capacity to maintain regulatory compliance, as well as the quality of the data collected and the speed with which studies are conducted.
China has one of the populations that is becoming older at one of the quickest rates in the world. It is anticipated that by the year 2040, the proportion of China's population that is over 60 years old will reach 28 percent, thanks to rising life expectancy and falling birth rates. This enormous demographic shift presents many new challenges and opportunities for public health and socioeconomic development; in particular, the advancement of an integrated system that appeals to the health and social requirements of older people, with comparable access to health care regardless of geographic area, is one of the most important of these new challenges and opportunities.
The China market dominated the Asia Pacific Electronic Data Capture Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $183.1 million by 2028.The Japan market is estimated to grow a CAGR of 14.1% during (2022 - 2028). Additionally, The India market would experience a CAGR of 15.5% during (2022 - 2028).
Based on Component, the market is segmented into Services and Software. Based on End User, the market is segmented into CROs, Pharmaceutical & Biotechnology Firms, Hospitals/Healthcare providers, Medical Device Firms and Others. Based on Development Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Delivery Mode, the market is segmented into Web & Cloud-based and On-premise. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, IBM Corporation, Veeva Systems, Inc., IQVIA Holdings, Inc., Medidata Solutions, Inc. (Dassault Systems SE), OpenClinica, LLC, DATATRAK International, Inc., Clario, Castor EDC, and Calyx.
Scope of the Study
Market Segments Covered in the Report:
By Component
- Services
- Software
By End-user
- CROs
- Pharmaceutical & Biotechnology Firms
- Hospitals/Healthcare providers
- Medical Device Firms
- Others
By Development Phase
- Phase III
- Phase II
- Phase I
- Phase IV
By Delivery Mode
- Web & Cloud-based
- On-premise
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Oracle Corporation
- IBM Corporation
- Veeva Systems, Inc
- IQVIA Holdings, Inc
- Medidata Solutions, Inc. (Dassault Systems SE)
- OpenClinica, LLC
- DATATRAK International, Inc
- Clario
- Castor EDC
- Calyx
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Electronic Data Capture Systems Market, by Component
1.4.2 Asia Pacific Electronic Data Capture Systems Market, by End-user
1.4.3 Asia Pacific Electronic Data Capture Systems Market, by Development Phase
1.4.4 Asia Pacific Electronic Data Capture Systems Market, by Delivery Mode
1.4.5 Asia Pacific Electronic Data Capture Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Oct - 2022, Dec) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Agreements and Collaboration : 2021, Sep - 2022, Nov) Leading Players
Chapter 4. Asia Pacific Electronic Data Capture Systems Market by Component
4.1 Asia Pacific Services Market by Country
4.2 Asia Pacific Software Market by Country
Chapter 5. Asia Pacific Electronic Data Capture Systems Market by End-user
5.1 Asia Pacific CROs Market by Country
5.2 Asia Pacific Pharmaceutical & Biotechnology Firms Market by Country
5.3 Asia Pacific Hospitals/Healthcare providers Market by Country
5.4 Asia Pacific Medical Device Firms Market by Country
5.5 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Electronic Data Capture Systems Market by Development Phase
6.1 Asia Pacific Phase III Market by Country
6.2 Asia Pacific Phase II Market by Country
6.3 Asia Pacific Phase I Market by Country
6.4 Asia Pacific Phase IV Market by Country
Chapter 7. Asia Pacific Electronic Data Capture Systems Market by Delivery Mode
7.1 Asia Pacific Web & Cloud-based Market by Country
7.2 Asia Pacific On-premise Market by Country
Chapter 8. Asia Pacific Electronic Data Capture Systems Market by Country
8.1 China Electronic Data Capture Systems Market
8.1.1 China Electronic Data Capture Systems Market by Component
8.1.2 China Electronic Data Capture Systems Market by End-user
8.1.3 China Electronic Data Capture Systems Market by Development Phase
8.1.4 China Electronic Data Capture Systems Market by Delivery Mode
8.2 Japan Electronic Data Capture Systems Market
8.2.1 Japan Electronic Data Capture Systems Market by Component
8.2.2 Japan Electronic Data Capture Systems Market by End-user
8.2.3 Japan Electronic Data Capture Systems Market by Development Phase
8.2.4 Japan Electronic Data Capture Systems Market by Delivery Mode
8.3 India Electronic Data Capture Systems Market
8.3.1 India Electronic Data Capture Systems Market by Component
8.3.2 India Electronic Data Capture Systems Market by End-user
8.3.3 India Electronic Data Capture Systems Market by Development Phase
8.3.4 India Electronic Data Capture Systems Market by Delivery Mode
8.4 South Korea Electronic Data Capture Systems Market
8.4.1 South Korea Electronic Data Capture Systems Market by Component
8.4.2 South Korea Electronic Data Capture Systems Market by End-user
8.4.3 South Korea Electronic Data Capture Systems Market by Development Phase
8.4.4 South Korea Electronic Data Capture Systems Market by Delivery Mode
8.5 Singapore Electronic Data Capture Systems Market
8.5.1 Singapore Electronic Data Capture Systems Market by Component
8.5.2 Singapore Electronic Data Capture Systems Market by End-user
8.5.3 Singapore Electronic Data Capture Systems Market by Development Phase
8.5.4 Singapore Electronic Data Capture Systems Market by Delivery Mode
8.6 Malaysia Electronic Data Capture Systems Market
8.6.1 Malaysia Electronic Data Capture Systems Market by Component
8.6.2 Malaysia Electronic Data Capture Systems Market by End-user
8.6.3 Malaysia Electronic Data Capture Systems Market by Development Phase
8.6.4 Malaysia Electronic Data Capture Systems Market by Delivery Mode
8.7 Rest of Asia Pacific Electronic Data Capture Systems Market
8.7.1 Rest of Asia Pacific Electronic Data Capture Systems Market by Component
8.7.2 Rest of Asia Pacific Electronic Data Capture Systems Market by End-user
8.7.3 Rest of Asia Pacific Electronic Data Capture Systems Market by Development Phase
8.7.4 Rest of Asia Pacific Electronic Data Capture Systems Market by Delivery Mode
Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 IBM Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Veeva Systems, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 IQVIA Holdings, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 Medidata Solutions, Inc. (Dassault Systems SE)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 OpenClinica, LLC
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 DATATRAK International, Inc.
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Product Launches and Product Expansions:
9.8 Clario
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Partnerships, Collaborations, and Agreements:
9.9 Castor EDC
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calyx
9.10.1 Company Overview
Companies Mentioned
- Oracle Corporation
- IBM Corporation
- Veeva Systems, Inc.
- IQVIA Holdings, Inc.
- Medidata Solutions, Inc. (Dassault Systems SE)
- OpenClinica, LLC
- DATATRAK International, Inc.
- Clario
- Castor EDC
- Calyx
Methodology
LOADING...
